Hepatitis A virus antibodies in Belgium: relationship between prevalence and age
- PMID: 1963883
- DOI: 10.1007/BF01646408
Hepatitis A virus antibodies in Belgium: relationship between prevalence and age
Abstract
Epidemiological data from various countries show that the frequency of Hepatitis A virus antibodies (anti-HAV) in different population groups is largely dependent on the geographical and age distribution of the population surveyed. As regards Europe anti-HAV antibodies are generally frequent in all groups in Southern Europe while in Northern Europe these antibodies are common in older people only. The prevalence data collected in 1979 and in 1989 show that the anti-HAV antibodies rate is a function of age, but the rates for all age groups were lower in 1989 compared to 1979. In 1979, at an age between 25 and 30, some 50% of the population was anti-HAV antibody positive. The same results were obtained in another Belgian study conducted in 1979. In 1989 50% positivity was only reached at an age between 35 and 40 years. The present study confirms that anti-HAV antibody prevalence decreases with higher socioeconomic status. The higher rate relative to age is associated with socioeconomic and hygienic living conditions at the time when most infections occur, i.e. before the age of 20. It can be concluded by comparing the 1979 and 1989 results that the number of adults susceptible to HAV infections has increased. This fact drew attention in view of the strongly altered travelling pattern of fairly large sections of the population.
Similar articles
-
Prevalence of antibodies to hepatitis viruses in blood donors with a clinical history of hepatitis.Zentralbl Bakteriol. 1992 Apr;276(4):540-7. doi: 10.1016/s0934-8840(11)80680-8. Zentralbl Bakteriol. 1992. PMID: 1319249
-
The shift in prevalence of hepatitis A immunity in Flanders, Belgium.Acta Gastroenterol Belg. 1998 Jan-Mar;61(1):4-7. Acta Gastroenterol Belg. 1998. PMID: 9629763
-
Hepatitis A antibodies: prevalence in Saudi Arabia.J Trop Med Hyg. 1989 Dec;92(6):427-30. J Trop Med Hyg. 1989. PMID: 2558227
-
Epidemiological patterns of hepatitis A in different parts of the world.Vaccine. 1992;10 Suppl 1:S56-8. doi: 10.1016/0264-410x(92)90544-t. Vaccine. 1992. PMID: 1335660 Review.
-
History and epidemiology of hepatitis A virus.J Infect Dis. 1995 Mar;171 Suppl 1:S2-8. doi: 10.1093/infdis/171.supplement_1.s2. J Infect Dis. 1995. PMID: 7876643 Review.
Cited by
-
Seroprevalence of hepatitis A virus antibodies in a pediatric population of southern Spain.Infection. 1995 Sep-Oct;23(5):309. doi: 10.1007/BF01716294. Infection. 1995. PMID: 8557393 No abstract available.
-
The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries.Eur J Epidemiol. 2000 Jun;16(6):507-10. doi: 10.1023/a:1007628021661. Eur J Epidemiol. 2000. PMID: 11049092
-
Prevalence of hepatitis A antibodies in Swiss travellers.Eur J Epidemiol. 1993 Jan;9(1):50-4. doi: 10.1007/BF00463089. Eur J Epidemiol. 1993. PMID: 8386103
-
Prevalence of hepatitis A, B and C in the Flemish population.Eur J Epidemiol. 1997 Apr;13(3):275-80. doi: 10.1023/a:1007393405966. Eur J Epidemiol. 1997. PMID: 9258525
-
Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation.Infection. 1994 Jan-Feb;22(1):53-5. doi: 10.1007/BF01780769. Infection. 1994. PMID: 8181844
References
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials